You just read:

AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients

News provided by

AiCuris GmbH & Co. KG

08 May, 2014, 16:04 BST